At present, most hospitals collect blood, mostly using metal needles or lancet, which is not only painful, but also prone to cross-infection. For diabetics who have to measure their blood sugar every day, it can be even more painful to have their blood taken with needles. In addition, the use of needles as medical solid waste, improper disposal is also easy to cause environmental pollution.
“In popular terms, laser blood collection is a laser shot into the dermis, causing the blood in the capillaries of the dermis to be heated instantly, the volume to expand, the pressure of the blood vessels to rise rapidly, the blood will spatter out.” Shaokun Peng, project manager of innovation center, explained that compared with acupuncture, laser blood sampling instrument is non-contact blood sampling operation, avoiding cross-infection, and less painful, easy to operate, low price, broad market prospects.
Due to the differences in the medical systems of China and Russia, the first task of the company in the next stage is to complete the CFDA (Chinese medical product registration) certification. “The laser blood collection instrument belongs to the second class medical device, which is expected to be certified next year.” “Said Ruifa Lou.
It is worth mentioning that laser blood collection instrument has been officially used in Russia last year, which has achieved a good response. If we want to expand the market in China in the future, the product process design should be further adapted to the domestic market demand. At present, for the domestic market, smaller laser blood instrument has been developed, the company’s first generation of products have been basically formed.
After the establishment of the company, how to open up the situation? Lou said that from the perspective of product positioning, the laser blood collection instrument is still mainly medical, mainly for hospitals to sell, in the basic popularity of hospitals, users accept the situation, then adjust the strategy of products for home use. “The headquarters of the company is located in Dongguan, so the company plans to use Dongguan as the basic point. After the market stabilizes, the product radiates to the entire greater bay area, then spreads to the whole country.” “Said Lou.
“As a high-tech project, we are full of confidence, because the cooperation with the Russian side of the laser technology core – yttrium erbium garnet.” Although the company is just starting out, more than 10 medical institutions have expressed their willingness to cooperate, and if the cooperation is reached, more than 2,000 laser blood collection instruments will be put on the market, Lou said.
Reported by Dongguan Daily and Dongguan Times on Sep.2rd,2109.